10.65
price down icon5.25%   -0.59
after-market After Hours: 10.67 0.02 +0.19%
loading

Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
6.47%
67.38
63.28 65.43 68.76 62.19
Interest Income/Expense
0.21%
0.471
0.47 0.469 0.468 0.468
Operating Income/Loss
6.47%
-67.38
-63.28 -65.43 -68.76 -62.19
Income/Loss From Continuing Operations Before Tax
4.01%
-62.05
-59.66 -61.90 -65.70 -58.34
Income/Loss From Continuing Operations After Tax
4.01%
-62.05
-59.66 -61.90 -65.70 -58.34
Net Income/Loss
4.01%
-62.05
-59.66 -61.90 -65.70 -58.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,876%
93.55
3.1433 82.64 80.47 79.45
Diluted Average Shares
2,876%
93.55
3.1433 82.64 80.47 79.45
Basic Earnings Per Share
6.45%
-0.66
-0.62 -0.75 -0.82 -0.73
Diluted Earnings Per Share
6.45%
-0.66
-0.62 -0.75 -0.82 -0.73
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):